Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction

por Fitz, Judith, Edelmann, Frank, Hasenfuß, Gerd, Sandek, Anja, Nolte, Kathleen, Hashemi, Djawid, Trippel, Tobias D., Wachter, Rolf, Herrmann‐Lingen, Christoph
Publicado 2021

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

por Hashemi, Djawid, Dettmann, Ludwig, Trippel, Tobias D., Holzendorf, Volker, Petutschnigg, Johannes, Wachter, Rolf, Hasenfuß, Gerd, Pieske, Burkert, Zapf, Antonia, Edelmann, Frank
Publicado 2020

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial

por Schnelle, Moritz, Leha, Andreas, Eidizadeh, Abass, Fuhlrott, Katharina, Trippel, Tobias D., Hashemi, Djawid, Toischer, Karl, Wachter, Rolf, Herrmann-Lingen, Christoph, Hasenfuß, Gerd, Pieske, Burkert, Binder, Lutz, Edelmann, Frank
Publicado 2021

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort

por Hashemi, Djawid, Mende, Meinhard, Trippel, Tobias D., Petutschnigg, Johannes, Hasenfuss, Gerd, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Feuerstein, Anna, Langhammer, Romy, Tschöpe, Carsten, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank
Publicado 2022

Validation of the FEW16 questionnaire for the assessment of physical well‐being in patients with heart failure with reduced ejection fraction: results from the CIBIS‐ELD study

por Tahirović, E., Lashki, D. J., Trippel, T. D., Tscholl, V., Fritschka, M., Musial‐Bright, L., Busjahn, A., Kolip, P., Störk, S., Rauchfuß, M., Inkrot, S., Lainscak, M., Apostolović, S., Vesković, J., Lončar, G., Doehner, W., Zelenak, C., Düngen, H. D.
Publicado 2015